JenaValve

<!-- Name:DistributionId Value:8842609 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4535 -->…

IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that it has…

IRVINE, Kalifornien, Oct. 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., Entwickler und Hersteller von differenzierten Transkatheter-Aortenklappenimplantationssystemen (TAVI) (auch als Transkatheter-Aortenklappenersatz oder…

IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced the first commercial implants with the…